LivaNova (LIVN) Payout Ratio (2016 - 2017)
LivaNova's (LIVN) quarterly Payout Ratio came in at 0.4 in Q1 2017, up 1050.8% year-over-year from 0.04 in Q1 2016, and up 1424.7% quarter-over-quarter from 0.03 in Q4 2016.
Powered by 
Analysis
LivaNova (LIVN) Payout Ratio (2016 - 2017) Analysis & Trends
LivaNova has disclosed Payout Ratio across 2 years of filings, most recently posting 0.4 for Q1 2017.
- In Q1 2017, Payout Ratio rose 1050.8% year-over-year to 0.4; the TTM figure through Mar 2017 stood at 0.3 (changed N/A YoY), while the FY2016 annual figure was 0.14, changed N/A from the prior year.
- Payout Ratio came in at 0.4 for Q1 2017 at LivaNova, up from 0.03 in the prior quarter.
- In the past five years, Payout Ratio ranged from a high of 0.79 in Q3 2016 to a low of 0.04 in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 0.40 |
| Dec 31, 2016 | -0.03 |
| Sep 30, 2016 | 0.79 |
| Mar 31, 2016 | -0.04 |